New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Il rapporto

Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo

3 report e oltre

Aggiornato quotidianamente con le ultime intelligence di mercato

AdvanCell Raises $315M Series D for Targeted Alpha Therapies

AdvanCell closed an oversubscribed, upsized $315 million Series D led by Ally Bridge Group and co-led by Alpha Wave to advance ADVC001 toward Phase 3 and expand U.S. manufacturing.

AdvanCell Raises $112M in Series C

AdvanCell, a HealthTech company based in San Francisco, CA, has raised $112M in Series C at a $700M valuation led by Deerfield Management, Logos Capital.

Fundraising News Team

AdvanCell raises $112M Series C at $700M valuation

AdvanCell raises $112M in Series C at $700M valuation. Radionuclide cancer therapies...

Editorial Team

Feb 1, 2025

0 min read•$112M

Pagina 1

Visualizzazione di 3 report • Pagina 1 • Categoria: all

Rimani avanti rispetto al mercato

Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.